Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)
China flag China · Delayed Price · Currency is CNY
7.42
+0.10 (1.37%)
Feb 4, 2026, 3:00 PM CST

SHA:603168 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
100.7482.79355.67525.06138.52106.78
Short-Term Investments
-----100
Trading Asset Securities
122.39106.8613.5329.27105.03250
Cash & Short-Term Investments
223.13189.65369.2554.33243.55456.78
Cash Growth
12.15%-48.63%-33.40%127.60%-46.68%-33.07%
Accounts Receivable
49.6467.7953.5840.3252.04112.96
Other Receivables
12.0912.848.6942.965.163.06
Receivables
61.7380.6262.2783.2857.2116.02
Inventory
118.6576.6684.3259.160.8256.53
Other Current Assets
14.5219.7436.8731.09192.3718.31
Total Current Assets
418.03366.67552.66727.8553.95647.65
Property, Plant & Equipment
802.89841.87795.34651.26474.12507.27
Long-Term Investments
324.22327.64232.1467.86--
Goodwill
336.31332.09365.43326.68336.16336.16
Other Intangible Assets
146.04150.41154.62160.14165.72177.29
Long-Term Deferred Tax Assets
1.470.780.740.820.070.08
Long-Term Deferred Charges
84.0767.7330.454.741.873.37
Other Long-Term Assets
18.8219.0738.9117.1853.471.09
Total Assets
2,1322,1062,1701,9561,5851,673
Accounts Payable
125.68137.04123.1180.8525.9333.88
Accrued Expenses
14.1968.8153.0653.969.8661.2
Short-Term Debt
150.18105.2985.98---
Current Portion of Long-Term Debt
-4.110.41---
Current Portion of Leases
-8.058.545.93--
Current Income Taxes Payable
5.891.314.52-3.86.89
Current Unearned Revenue
14.4119.7126.3949.7534.4933.39
Other Current Liabilities
50.8433.1655.6815.3961.2226.57
Total Current Liabilities
361.18377.47367.7205.82195.27361.92
Long-Term Debt
129.42111.5537.07---
Long-Term Leases
15.5425.3433.6833.7637.61-
Long-Term Unearned Revenue
2.92.222.47--2.63
Long-Term Deferred Tax Liabilities
4.21--1.42--
Other Long-Term Liabilities
-----2.24
Total Liabilities
513.25516.59440.92240.99232.89366.78
Common Stock
375.93375.93379.16372.51322.59322.59
Additional Paid-In Capital
906903.73912.8888.99630.63619.94
Retained Earnings
350.97324.3455.64444399.25363.59
Treasury Stock
-14.33-14.33-27.92---
Total Common Equity
1,6191,5901,7201,7051,3521,306
Minority Interest
0.030.049.710--
Shareholders' Equity
1,6191,5901,7291,7151,3521,306
Total Liabilities & Equity
2,1322,1062,1701,9561,5851,673
Total Debt
295.14254.34175.6939.6937.61-
Net Cash (Debt)
-72.01-64.69193.51514.64205.94456.78
Net Cash Growth
---62.40%149.90%-54.92%-33.07%
Net Cash Per Share
-0.19-0.170.531.610.641.43
Filing Date Shares Outstanding
375.93375.93379.16372.51322.59322.59
Total Common Shares Outstanding
375.93375.93379.16372.51322.59322.59
Working Capital
56.85-10.81184.96521.99358.67285.73
Book Value Per Share
4.314.234.544.584.194.05
Tangible Book Value
1,1361,1071,2001,219850.59792.67
Tangible Book Value Per Share
3.022.953.163.272.642.46
Buildings
-373.99372.77372.77371.38439.79
Machinery
-571.12528.14391.32364.87366.7
Construction In Progress
-335.22273.35207.598.131.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.